{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:25:07Z","timestamp":1791217507293,"version":"4.1.0"},"reference-count":140,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T00:00:00Z","timestamp":1682208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>One of the most common cyclitols found in eukaryotic cells\u2014Myo-inositol (MI) and its derivatives play a key role in many cellular processes such as ion channel physiology, signal transduction, phosphate storage, cell wall formation, membrane biogenesis and osmoregulation. The aim of this paper is to characterize the possibility of neurodegenerative disorders treatment using MI and the research of other therapeutic methods linked to MI\u2019s derivatives. Based on the reviewed literature the researchers focus on the most common neurodegenerative diseases such as Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease and Spinocerebellar ataxias, but there are also works describing other seldom encountered diseases. The use of MI, d-pinitol and other methods altering MI\u2019s metabolism, although research on this topic has been conducted for years, still needs much closer examination. The dietary supplementation of MI shows a promising effect on the treatment of neurodegenerative disorders and can be of great help in alleviating the accompanying depressive symptoms.<\/jats:p>","DOI":"10.3390\/nu15092029","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T02:06:11Z","timestamp":1682301971000},"page":"2029","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cyclitols: From Basic Understanding to Their Association with Neurodegeneration"],"prefix":"10.3390","volume":"15","author":[{"given":"Maria","family":"Derkaczew","sequence":"first","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland"},{"name":"Students\u2019 Scientific Club of Pathophysiologists, Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Martyniuk","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland"},{"name":"Students\u2019 Scientific Club of Pathophysiologists, Department of Human Physiology and Pathophysiology, School of Medicine, University of Warmia and Mazury, 10-082 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Osowski","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-3644","authenticated-orcid":false,"given":"Joanna","family":"Wojtkiewicz","sequence":"additional","affiliation":[{"name":"Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-082 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Antonowski, T., Osowski, A., Lahuta, L., G\u00f3recki, R., Rynkiewicz, A., and Wojtkiewicz, J. (2019). Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes. Nutrients, 11.","DOI":"10.3390\/nu11102314"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/17425255.2016.1206887","article-title":"Pharmacodynamics and Pharmacokinetics of Inositol(s) in Health and Disease","volume":"12","author":"Bizzarri","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Owczarczyk-Saczonek, A., Lahuta, L.B., Ligor, M., Placek, W., G\u00f3recki, R.J., and Buszewski, B. (2018). The Healing-Promoting Properties of Selected Cyclitols\u2014A Review. Nutrients, 10.","DOI":"10.3390\/nu10121891"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wi\u015bniewski, K., Jozwik, M., and Wojtkiewicz, J. (2020). Cancer Prevention by Natural Products Introduced into the Diet\u2014Selected Cyclitols. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238988"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Majumder, A.L., and Biswas, B.B. (2006). Biology of Inositols and Phosphoinositides: Subcellular Biochemistry, Springer. Subcellula.","DOI":"10.1007\/0-387-27600-9"},{"key":"ref_6","unstructured":"National Center for Biotechnology Information (2023, April 18). PubChem Compound Summary for CID 892, Inositol, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Inositol."},{"key":"ref_7","unstructured":"Szkodziak, P., and Paszkowski, T. (2016, November 05). Wp\u0142yw Leczenia Mio-Inozytolem Na Insulinooporno\u015b\u0107 u Pacjentek z Zespo\u0142em Policystycznych Jajnik\u00f3w w Obserwacji 3-Miesi\u0119cznej. Available online: https:\/\/inofem.pl\/wp-content\/uploads\/2022\/03\/Inofem-Badanie-kliniczne.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential Role and Therapeutic Interests of Myo-Inositol in Metabolic Diseases","volume":"95","author":"Croze","year":"2013","journal-title":"Biochimie"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"114915","DOI":"10.1016\/j.anifeedsci.2021.114915","article-title":"Phytic Acid in Rhamdia Quelen Nutrition: Antioxidant or Antinutrient?","volume":"276","author":"Adorian","year":"2021","journal-title":"Anim. Feed Sci. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.adgen.2020.11.003","article-title":"Diverse Role of Phytic Acid in Plants and Approaches to Develop Low-Phytate Grains to Enhance Bioavailability of Micronutrients","volume":"107","author":"Pramitha","year":"2021","journal-title":"Adv. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1002\/mnfr.200900099","article-title":"Phytate in Foods and Significance for Humans: Food Sources, Intake, Processing, Bioavailability, Protective Role and Analysis","volume":"53","author":"Schlemmer","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2014.01.021","article-title":"A Bacterial Homolog of a Eukaryotic Inositol Phosphate Signaling Enzyme Mediates Cross-Kingdom Dialog in the Mammalian Gut","volume":"6","author":"Stentz","year":"2014","journal-title":"Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0308-8146(01)00144-3","article-title":"Content of Phytic Acid and HCl-Extractability of Calcium, Phosphorus and Iron as Affected by Various Domestic Processing and Cooking Methods","volume":"78","author":"Duhan","year":"2002","journal-title":"Food Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1301\/00296640260042748","article-title":"Involvement of Inositol in Reproduction","volume":"60","author":"Beemster","year":"2002","journal-title":"Nutr. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuint.2012.04.010","article-title":"Contributions in Astrocytes of SMIT1\/2 and HMIT to Myo-Inositol Uptake at Different Concentrations and PH","volume":"61","author":"Fu","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E3290","DOI":"10.1073\/pnas.1606348113","article-title":"Osmoregulatory Inositol Transporter SMIT1 Modulates Electrical Activity by Adjusting PI(4,5)P2 Levels","volume":"113","author":"Dai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","first-page":"2390","article-title":"From Myo-Inositol to d-Chiro-Inositol Molecular Pathways","volume":"25","author":"Kiani","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1093\/emboj\/20.16.4467","article-title":"Identification of a Mammalian H+-Myo-Inositol Symporter Expressed Predominantly in the Brain","volume":"20","author":"Uldry","year":"2001","journal-title":"EMBO J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.36129\/jog.2022.40","article-title":"Inositols Administration: Further Insights on Their Biological Role","volume":"35","author":"Coldebella","year":"2023","journal-title":"Ital. J. Gynaecol. Obstet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1016\/S0021-9258(19)70191-4","article-title":"Stereochemistry of the Myo-Inositol-1-Phosphate Synthase Reaction","volume":"255","author":"Loewus","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wojciechowska, A., Osowski, A., J\u00f3\u017awik, M., G\u00f3recki, R., Rynkiewicz, A., and Wojtkiewicz, J. (2019). Inositols\u2019 Importance in the Improvement of the Endocrine\u2013Metabolic Profile in PCOS. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225787"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"F755","DOI":"10.1152\/ajprenal.00164.2015","article-title":"Renal Depletion of Myo-Inositol Is Associated with Its Increased Degradation in Animal Models of Metabolic Disease","volume":"309","author":"Chang","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1369-5266(03)00039-6","article-title":"The Oxidative Pentose Phosphate Pathway: Structure and Organisation","volume":"6","author":"Kruger","year":"2003","journal-title":"Curr. Opin. Plant Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Alfarouk, K.O., Ahmed, S.B.M., Elliott, R.L., Benoit, A., Alqahtani, S.S., Ibrahim, M.E., Bashir, A.H.H., Alhoufie, S.T.S., Elhassan, G.O., and Wales, C.C. (2020). The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular PH. Metabolites, 10.","DOI":"10.3390\/metabo10070285"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1111\/febs.14366","article-title":"Inositol 1,4,5-Trisphosphate Receptors and Neurodegenerative Disorders","volume":"285","author":"Egorova","year":"2018","journal-title":"FEBS J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceca.2014.08.002","article-title":"Toward a High-Resolution Structure of IP3R Channel","volume":"56","author":"Serysheva","year":"2014","journal-title":"Cell Calcium"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bbrc.2016.09.088","article-title":"Emerging Pathways Driving Early Synaptic Pathology in Alzheimer\u2019s Disease","volume":"483","author":"Briggs","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_28","first-page":"re15","article-title":"(IP 3 R) and Its Regulators: Sometimes Good and sometimes bad teamwork","volume":"363","author":"Choe","year":"2006","journal-title":"Sci. STKE"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1007\/s12035-016-0205-8","article-title":"Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic","volume":"54","author":"Takada","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Gambero, A.J., Sanjuan, C., Serrano-Castro, P.J., Su\u00e1rez, J., and De Fonseca, F.R. (2020). The Biomedical Uses of Inositols: A Nutraceutical Approach to Metabolic Dysfunction in Aging and Neurodegenerative Diseases. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090295"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neuroimage.2010.10.017","article-title":"In Vivo Mapping of Brain Myo-Inositol","volume":"54","author":"Haris","year":"2011","journal-title":"Neuroimage"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/anie.201502227","article-title":"The \u201cOther\u201d Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in Myo-Inositol Chemistry)","volume":"55","author":"Thomas","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mrm.1910390220","article-title":"Identification of a High Concentration of Scyllo-Inositol in the Brain of a Healthy Human Subject Using 1H- and 13C-NMR","volume":"39","author":"Seaquist","year":"1998","journal-title":"Magn. Reson. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1152\/ajplegacy.1975.229.3.777","article-title":"Folate Transport in the Central Nervous System","volume":"229","author":"Spector","year":"1975","journal-title":"Am. J. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2010.03.011","article-title":"Detection of Increased Scyllo-Inositol in Brain with Magnetic Resonance Spectroscopy after Dietary Supplementation in Alzheimer\u2019s Disease Mouse Models","volume":"59","author":"Choi","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.parkreldis.2018.12.008","article-title":"In Vivo Evidence for Decreased Scyllo-Inositol Levels in the Supplementary Motor Area of Patients with Progressive Supranuclear Palsy: A Proton MR Spectroscopy Study","volume":"62","author":"Barbagallo","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","article-title":"Alzheimer Disease","volume":"287","author":"Cummings","year":"2002","journal-title":"Jama"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s Disease Facts and Figures","volume":"12","author":"Gaugler","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s Disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1749-6632.2002.tb02109.x","article-title":"Alzheimer\u2019s Disease: Role of Aging in Pathogenesis","volume":"959","author":"Harman","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/5.Supplement_1.1449","article-title":"The Presenilin Genes: A New Gene Family Involved in Alzheimer Disease Pathology","volume":"5","author":"Cruts","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J","article-title":"Presenilin Mutations in Alzheimer\u2019s Disease","volume":"11","author":"Cruts","year":"1998","journal-title":"Hum. Mutat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/6.10.1639","article-title":"The Presenilins and Alzheimer\u2019s Disease","volume":"6","author":"Hutton","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Go\u0142aszewska, A., Bik, W., Motyl, T., and Orzechowski, A. (2019). Bridging the Gap between Alzheimer\u2019s Disease and Alzheimer\u2019s-like Diseases in Animals. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071664"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"23515","DOI":"10.1074\/jbc.R115.677211","article-title":"Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), A\u03b242, and Tau in Nuclear Roles","volume":"290","author":"Multhaup","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and Disadvantages of the Use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 Ratio in the Diagnosis of Alzheimer\u2019s Disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bss0670177","article-title":"Dysfunctional Intracellular Calcium Homoeostasis: A Central Cause of Neurodegeneration in Alzheimer\u2019s Disease","volume":"67","author":"Cowburn","year":"2001","journal-title":"Biochem. Soc. Symp."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1176\/ajp.156.12.1879","article-title":"High Brain Myo-Inositol Levels in the Predementia Phase of Alzheimer\u2019s Disease in Adults with Down\u2019s Syndrome: A 1H MRS Study","volume":"156","author":"Huang","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000261646","article-title":"Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer\u2019s Disease in APP\/PS1 Transgenic Mice","volume":"28","author":"Chen","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_50","first-page":"709","article-title":"Elevated Brain Scyllo-inositol Concentrations in Patients with Alzheimer\u2019s Disease","volume":"20","author":"Griffith","year":"2007","journal-title":"NMR Biomed. Int. J. Devoted Dev. Appl. Magn. Reson. In Vivo"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000064927","article-title":"A Comprehensive Review of Proton Magnetic Resonance Spectroscopy","volume":"14","author":"Firbank","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bbamcr.2013.01.012","article-title":"Analysis of Calcium Homeostasis in Fresh Lymphocytes from Patients with Sporadic Alzheimer\u2019s Disease or Mild Cognitive Impairment","volume":"1833","author":"Jaworska","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.1021\/acsomega.1c06990","article-title":"Brain Metabolite, Myo-Inositol, Inhibits Catalase Activity: A Mechanism of the Distortion of the Antioxidant Defense System in Alzheimer\u2019s Disease","volume":"7","author":"Ali","year":"2022","journal-title":"ACS Omega"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(05)61449-3","article-title":"Prediction of Cognitive Decline in Early Alzheimer\u2019s Disease","volume":"352","author":"Doraiswamy","year":"1998","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1096\/fj.201801751R","article-title":"Ca2+ Homeostasis Dysregulation in Alzheimer\u2019s Disease: A Focus on Plasma Membrane and Cell Organelles","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0197-4580(91)90075-U","article-title":"Inositol Phosphates and Intracellular Calcium after Bradykinin Stimulation in Fibroblasts from Young, Normal Aged and Alzheimer Donors","volume":"12","author":"Huang","year":"1991","journal-title":"Neurobiol. Aging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The Inositol Trisphosphate\/Calcium Signaling Pathway in Health and Disease","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.bbamcr.2014.11.023","article-title":"Structural Insights into Endoplasmic Reticulum Stored Calcium Regulation by Inositol 1,4,5-Trisphosphate and Ryanodine Receptors","volume":"1853","author":"Seo","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00702-012-0822-y","article-title":"Folate and Alzheimer: When Time Matters","volume":"120","author":"Hinterberger","year":"2013","journal-title":"J. Neural Transm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0006-291X(02)00346-7","article-title":"Mechanism of Membrane Depolarization Caused by the Alzheimer A\u03b21-42 Peptide","volume":"293","author":"Blanchard","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/355356a0","article-title":"E. Inositol 1, 3, 4, 5-Tetrakisphosphate Activates an Endothelial Ca2+-Permeable Channel","volume":"355","author":"Clapham","year":"1992","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0306-4522(94)90597-5","article-title":"Inositol 1,3,4,5-Tetrakisphosphate as a Mediator of Neuronal Death in Ischemic Hippocampus","volume":"59","author":"Tsubokawa","year":"1994","journal-title":"Neuroscience"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/neur.1996.0024","article-title":"Decreased inositol (1, 4, 5)-trisphosphate receptor levels in Alzheimer\u2019s disease cerebral cortex: Selectivity of changes and possible correlation to pathological severity","volume":"5","author":"Haug","year":"1996","journal-title":"Neurodegeneration"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0304-3940(88)90295-9","article-title":"Decreased Brain [3H]Inositol 1,4,5-Trisphosphate Binding in Alzheimer\u2019s Disease","volume":"94","author":"Young","year":"1988","journal-title":"Neurosci. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Mak, D.O.D., Cheung, K.H., Toglia, P., Foskett, J.K., and Ullah, G. (2015). Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer\u2019s Disease-Causing Mutants in Presenilins. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004529"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"ra22","DOI":"10.1126\/scisignal.2000818","article-title":"Gain-of-Function Enhancement of IP3 Receptor Modal Gating by Familial Alzheimer\u2019s Disease-Linked Presenilin Mutants in Human Cells and Mouse Neurons","volume":"3","author":"Cheung","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ceca.2016.05.002","article-title":"The Gain-of-Function Enhancement of IP3-Receptor Channel Gating by Familial Alzheimer\u2019s Disease-Linked Presenilin Mutants Increases the Open Probability of Mitochondrial Permeability Transition Pore","volume":"60","author":"Toglia","year":"2016","journal-title":"Cell Calcium"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00429-009-0227-3","article-title":"Presenilin Transgenic Mice as Models of Alzheimer\u2019s Disease","volume":"214","author":"Elder","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","article-title":"What Is the Mitochondrial Permeability Transition Pore?","volume":"46","author":"Halestrap","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"20796","DOI":"10.1074\/jbc.M109.025353","article-title":"Calcium Elevation in Mitochondria Is the Main Ca2+ Requirement for Mitochondrial Permeability Transition Pore (MPTP) Opening","volume":"284","author":"Baumgartner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1523\/JNEUROSCI.5441-13.2014","article-title":"Suppression of InsP3 Receptor-Mediated Ca2+ Signaling Alleviates Mutant Presenilin-Linked Familial Alzheimer\u2019s Disease Pathogenesis","volume":"34","author":"Shilling","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1749-6632.1994.tb44402.x","article-title":"Calcium-Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer\u2019s Disease","volume":"747","author":"Nixon","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2183\/pjab.87.287","article-title":"Calpain chronicle\u2014An enzyme family under multidisciplinary characterization. 2011, 87, 287-327","volume":"87","author":"Sorimachi","year":"2011","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"15229","DOI":"10.1074\/jbc.M500939200","article-title":"Distinct Mechanistic Roles of Calpain and Caspase Activation in Neurodegeneration as Revealed in Mice Overexpressing Their Specific Inhibitors","volume":"280","author":"Higuchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1523\/JNEUROSCI.4119-08.2008","article-title":"Marked Calpastatin (CAST) Depletion in Alzheimer\u2019s Disease Accelerates Cytoskeleton Disruption and Neurodegeneration: Neuroprotection by CAST Overexpression","volume":"28","author":"Rao","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/med.21534","article-title":"Involvement of Calpain in the Neuropathogenesis of Alzheimer\u2019s Disease","volume":"39","author":"Mahaman","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bbrc.2016.08.105","article-title":"Calcium\u2019s Role as Nuanced Modulator of Cellular Physiology in the Brain","volume":"483","author":"Frazier","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pbiomolbio.2018.03.001","article-title":"Catalase and Its Mysteries","volume":"140","year":"2018","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"9613090","DOI":"10.1155\/2019\/9613090","article-title":"Role of Catalase in Oxidative Stress-and Age-Associated Degenerative Diseases","volume":"2019","author":"Nandi","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/j.1365-2109.2009.02283.x","article-title":"Myo-Inositol Prevents Oxidative Damage, Inhibits Oxygen Radical Generation and Increases Antioxidant Enzyme Activities of Juvenile Jian Carp (Cyprinus Carpio Var. Jian)","volume":"40","author":"Jiang","year":"2009","journal-title":"Aquac. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson Disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2015.12.043","article-title":"\u03b1-Synuclein Aggregation, Seeding and Inhibition by Scyllo-Inositol","volume":"469","author":"Ibrahim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2015.12.035","article-title":"Neuroprotection of Inositol Hexaphosphate and Changes of Mitochondrion Mediated Apoptotic Pathway and \u03b1-Synuclein Aggregation in 6-OHDA Induced Parkinson\u2019s Disease Cell Model","volume":"1633","author":"Zhang","year":"2016","journal-title":"Brain Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02918905","article-title":"Inositol 1,4,5-Trisphosphate Binding Sites in the Brain: Regional Distribution, Characterization, and Alterations in Brains of Patients with Parkinson\u2019s Disease","volume":"1","author":"Kitamura","year":"1989","journal-title":"J. Mol. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/00006450-199807000-00001","article-title":"Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research","volume":"44","author":"Novotny","year":"1998","journal-title":"Pediatr. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2015142764","article-title":"Proton MR Spectroscopy for Diagnosis and Evaluation of Treatment Efficacy in Parkinson Disease","volume":"278","author":"Mazuel","year":"2016","journal-title":"Radiology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"519816","DOI":"10.1155\/2014\/519816","article-title":"Magnetic Resonance Spectroscopy: An in Vivo Molecular Imaging Biomarker for Parkinson\u2019s Disease?","volume":"2014","author":"Ciurleo","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00330-011-2123-5","article-title":"Three-Dimensional Magnetic Resonance Spectroscopic Imaging in the Substantia Nigra of Healthy Controls and Patients with Parkinson\u2019s Disease","volume":"21","author":"Chadzynski","year":"2011","journal-title":"Eur. Radiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/B978-1-4160-6641-5.00021-0","article-title":"Progressive Supranuclear Palsy","volume":"34","author":"Morris","year":"2010","journal-title":"Blue Books Neurol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I","article-title":"Inositol Is Not Therapeutic in Parkinson\u2019s Disease","volume":"14","author":"Mishori","year":"1999","journal-title":"Hum. Psychopharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s Disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"a007476","DOI":"10.1101\/cshperspect.a007476","article-title":"Huntington \u2019 s Disease","volume":"3","author":"Finkbeiner","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1460-9568.2004.03633.x","article-title":"HAP1 Facilitates Effects of Mutant Huntingtin on Inositol 1,4,5-Trisphosphate-Induced Ca2+ Release in Primary Culture of Striatal Medium Spiny Neurons","volume":"20","author":"Tang","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"E3966","DOI":"10.1073\/pnas.1409730111","article-title":"Aberrant Calcium Signaling by Transglutaminase-Mediated Posttranslational Modification of Inositol 1,4,5-Trisphosphate Receptors","volume":"111","author":"Hamada","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JHD-180301","article-title":"Differential Levels and Phosphorylation of Type 1 Inositol 1,4,5-Trisphosphate Receptor in Four Different Murine Models of Huntington Disease","volume":"8","author":"Post","year":"2019","journal-title":"J. Huntingtons Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s12035-015-9470-1","article-title":"Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation","volume":"53","author":"Nagata","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"26680","DOI":"10.1074\/jbc.M111.220749","article-title":"Inositol Hexakisphosphate Kinases Induce Cell Death in Huntington Disease","volume":"286","author":"Nagata","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/cge.12808","article-title":"Spinocerebellar Ataxia: Relationship between Phenotype and Genotype\u2014A Review","volume":"90","author":"Sun","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1523\/JNEUROSCI.1643-12.2012","article-title":"Chronic Suppression of Inositol 1,4,5-Triphosphate Receptor-Mediated Calcium Signaling in Cerebellar Purkinje Cells Alleviates Pathological Phenotype in Spinocerebellar Ataxia 2 Mice","volume":"32","author":"Kasumu","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pjnns.2016.10.006","article-title":"Spinocerebellar Ataxia 15: A Phenotypic Review and Expansion","volume":"51","author":"Tipton","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar Ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fnins.2014.00453","article-title":"Integration of Modeling with Experimental and Clinical Findings Synthesizes and Refines the Central Role of Inositol 1,4,5-Trisphosphate Receptor 1 in Spinocerebellar Ataxia","volume":"8","author":"Brown","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/mds.23223","article-title":"An ITPR1 Gene Deletion Causes Spinocerebellar Ataxia 15\/16: A Genetic, Clinical and Radiological Description","volume":"25","author":"Novak","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00415-015-7705-8","article-title":"Sporadic Infantile-Onset Spinocerebellar Ataxia Caused by Missense Mutations of the Inositol 1,4,5-Triphosphate Receptor Type 1 Gene","volume":"262","author":"Sasaki","year":"2015","journal-title":"J. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/jhg.2012.5","article-title":"Prevalence of Inositol 1, 4, 5-Triphosphate Receptor Type 1 Gene Deletion, the Mutation for Spinocerebellar Ataxia Type 15, in Japan Screened by Gene Dosage","volume":"57","author":"Obayashi","year":"2012","journal-title":"J. Hum. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajmg.a.37962","article-title":"A de Novo Missense Mutation in the Inositol 1,4,5-Triphosphate Receptor Type 1 Gene Causing Severe Pontine and Cerebellar Hypoplasia: Expanding the Phenotype of ITPR1-Related Spinocerebellar Ataxia\u2019s","volume":"173","author":"Barth","year":"2017","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2019.04.018","article-title":"Motor Cortex Metabolite Alterations in Amyotrophic Lateral Sclerosis Assessed in Vivo Using Edited and Non-Edited Magnetic Resonance Spectroscopy","volume":"1718","author":"Weerasekera","year":"2019","journal-title":"Brain Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1007\/s11033-020-05688-w","article-title":"Inositol Hexakisphosphate Kinase 2 Promotes Cell Death of Anterior Horn Cells in the Spinal Cord of Patients with Amyotrophic Lateral Sclerosis","volume":"47","author":"Nagata","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jnnp-2018-318795","article-title":"Neurochemical Correlates of Functional Decline in Amyotrophic Lateral Sclerosis","volume":"90","author":"Cheong","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/CPJ.0000000000000674","article-title":"Cerebral Degeneration in Amyotrophic Lateral Sclerosis: A Prospective Multicenter Magnetic Resonance Spectroscopy Study","volume":"9","author":"Srivastava","year":"2019","journal-title":"Neurol. Clin. Pract."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e2110629118","DOI":"10.1073\/pnas.2110629118","article-title":"IP3R-Driven Increases in Mitochondrial Ca2+ Promote Neuronal Death in NPC Disease","volume":"118","author":"Tiscione","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fphar.2019.01172","article-title":"Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases","volume":"10","author":"Chhetri","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nbd.2016.05.001","article-title":"Cognitive Deficits and Brain Myo-Inositol Are Early Biomarkers of Epileptogenesis in a Rat Model of Epilepsy","volume":"93","author":"Pascente","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_114","first-page":"6609","article-title":"d-Pinitol-A Natural Phytomolecule and Its Pharmacological Effect","volume":"11","author":"Dubey","year":"2020","journal-title":"Int. J. Pharm. Life Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11101-020-09677-6","article-title":"d-Pinitol: A Cyclitol with Versatile Biological and Pharmacological Activities","volume":"20","year":"2021","journal-title":"Phytochem. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0278-5846(96)00043-7","article-title":"Inositol Treatment of Alzheimer\u2019s Disease: A Double Blind, Cross-over Placebo Controlled Trial","volume":"20","author":"Barak","year":"1996","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1111\/bph.15907","article-title":"d-Pinitol Promotes Tau Dephosphorylation through a Cyclin-Dependent Kinase 5 Regulation Mechanism: A New Potential Approach for Tauopathies?","volume":"179","author":"Navarro","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol Stereoisomers Stabilize an Oligomeric Aggregate of Alzheimer Amyloid \u03b2 Peptide and Inhibit A\u03b2-Induced Toxicity","volume":"275","author":"McLaurin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00109-007-0156-7","article-title":"Properties of Scyllo-Inositol as a Therapeutic Treatment of AD-like Pathology","volume":"85","author":"Fenili","year":"2007","journal-title":"J. Mol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-160965","article-title":"A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (Scyllo-Inositol) in Young Adults with Down Syndrome without Dementia","volume":"58","author":"Rafii","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0b013e3182309fa5","article-title":"A Phase 2 Randomized Trial of ELND005, Scyllo-Inositol, in Mild to Moderate Alzheimer Disease","volume":"77","author":"Salloway","year":"2011","journal-title":"Neurology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymben.2021.06.011","article-title":"Metabolic Engineering of Corynebacterium Glutamicum for Production of Scyllo-Inositol, a Drug Candidate against Alzheimer\u2019s Disease","volume":"67","author":"Ramp","year":"2021","journal-title":"Metab. Eng."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-0814-7","article-title":"ichi A Bacterial Cell Factory Converting Glucose into Scyllo-Inositol, a Therapeutic Agent for Alzheimer\u2019s Disease","volume":"3","author":"Michon","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4161\/auto.2387","article-title":"Inositol and IP3 Levels Regulate Autophagy: Biology and Therapeutic Speculations","volume":"2","author":"Sarkar","year":"2006","journal-title":"Autophagy"},{"key":"ref_125","first-page":"51","article-title":"Lithium Salts-Mechanisms of Action|Mechanizmy Dzia\u0142ania Soli Litu","volume":"5","author":"Pietruczuk","year":"2008","journal-title":"Psychiatria"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fnins.2015.00403","article-title":"Potential Application of Lithium in Parkinson\u2019s and Other Neurodegenerative Diseases","volume":"9","author":"Lazzara","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_127","first-page":"78","article-title":"Neuroprotective Effects of Lithium: What Are the Implications in Humans with Neurodegenerative Disorders?","volume":"16","author":"Morlet","year":"2018","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ddr.21605","article-title":"Autophagy Induction in the Treatment of Alzheimer\u2019s Disease","volume":"81","author":"Schmukler","year":"2020","journal-title":"Drug Dev. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"119007","DOI":"10.1016\/j.lfs.2020.119007","article-title":"\u03b3-Secretase Inhibitors for Breast Cancer and Hepatocellular Carcinoma: From Mechanism to Treatment","volume":"268","author":"Jia","year":"2021","journal-title":"Life Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","article-title":"\u03b3-Secretase Inhibitors and Modulators","volume":"1828","author":"Golde","year":"2013","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1212\/NXI.0000000000000306","article-title":"Antibodies to Inositol 1,4,5-Triphosphate Receptor 1 in Patients with Cerebellar Disease","volume":"4","author":"Fouka","year":"2017","journal-title":"Neurol. Neuroimmunol. NeuroInflamm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1111\/bph.12685","article-title":"Interactions of Antagonists with Subtypes of Inositol 1, 4, 5-trisphosphate (IP 3) Receptor","volume":"171","author":"Saleem","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/17460441.2021.1858792","article-title":"The Discovery and Development of IP3 Receptor Modulators: An Update","volume":"16","author":"Gambardella","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3934\/agrfood.2018.1.41","article-title":"d-Pinitol, a Highly Valuable Product from Carob Pods: Health-Promoting Effects and Metabolic Pathways of This Natural Super-Food Ingredient and Its Derivatives","volume":"3","author":"Moreno","year":"2018","journal-title":"AIMS Agric. Food"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Azab, A. (2022). d-Pinitol\u2014Active Natural Product from Carob with Notable Insulin Regulation. Nutrients, 14.","DOI":"10.3390\/nu14071453"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ma, K., Thomason, L.A.M., and McLaurin, J.A. (2012). Scyllo-Inositol, Preclinical, and Clinical Data for Alzheimer\u2019s Disease, Elsevier Inc.","DOI":"10.1016\/B978-0-12-394816-8.00006-4"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1021\/acs.jctc.9b00599","article-title":"Modulation of Amyloid-\u039242 Conformation by Small Molecules through Nonspecific Binding","volume":"15","author":"Liang","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.1998.1677","article-title":"Phosphatidylinositol and Inositol Involvement in Alzheimer Amyloid-\u03b2 Fibril Growth and Arrest","volume":"278","author":"McLaurin","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-140984","article-title":"Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer\u2019s Disease","volume":"43","author":"Henriksen","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-015-0121-6","article-title":"Peripheral and Central Effects of \u03b3-Secretase Inhibition by Semagacestat in Alzheimer\u2019s Disease","volume":"7","author":"Doody","year":"2015","journal-title":"Alzheimers Res. Ther."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/9\/2029\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:21:33Z","timestamp":1760124093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/9\/2029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,23]]},"references-count":140,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["nu15092029"],"URL":"https:\/\/doi.org\/10.3390\/nu15092029","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,23]]}}}